F1SCHEDULE 3Sampling and analysisF1PART 3Monitoring for indicative dose and analytical performance characteristicsScreening strategies for gross alpha activity and gross beta activityF19.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .